Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119M
-
Number of holders
-
102
-
Total 13F shares, excl. options
-
28M
-
Shares change
-
+4.84M
-
Total reported value, excl. options
-
$360M
-
Value change
-
+$62.6M
-
Put/Call ratio
-
0.28
-
Number of buys
-
59
-
Number of sells
-
-41
-
Price
-
$12.85
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q1 2017
121 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q1 2017.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28M shares
of 119M outstanding shares and own 23.49% of the company stock.
Largest 10 shareholders include FMR LLC (5.66M shares), BVF INC/IL (4.26M shares), BlackRock Inc. (3.04M shares), LANSDOWNE PARTNERS (UK) LLP (2.32M shares), VANGUARD GROUP INC (1.95M shares), WASATCH ADVISORS INC (1.49M shares), WELLINGTON MANAGEMENT GROUP LLP (1.35M shares), STATE STREET CORP (932K shares), CITIGROUP INC (729K shares), and BALYASNY ASSET MANAGEMENT LLC (508K shares).
This table shows the top 102 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.